The Effect of Morphine Dosing on Length of Stay in Neonatal Abstinence Syndrome - An Alternative Viewpoint

We read with interest the recent study published in Pharmacotherapy evaluating morphine dosing to treat neonatal abstinence syndrome (NAS).1 The authors attempted to address an important research question in a disease state which is a widespread problem with many unknowns related to its management.2-4 In order to address these unknowns, future research of NAS should include the following key considerations. This article is protected by copyright. All rights reserved.